Development of rifapentine susceptibility tests for Mycobacterium tuberculosis

18Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Two methods for testing the susceptibility of Mycobacterium tuberculosis to rifapentine have been developed: the agar proportion method and the radiometric BACTEC technique. A critical concentration of 0.5 μg of rifapentine per ml is proposed for both methods since it provides a reliable means of distinguishing between susceptible and resistant M. tuberculosis isolates. It is recommended that two quality control M, tuberculosis strains be used at the introduction of these tests in a clinical laboratory: one that is pansusceptible (H37Rv) and one that is resistant to rifapentine. The resistant strain can be obtained from the American Type Culture Collection, where it is deposited under the number ATCC 700457.

Cite

CITATION STYLE

APA

Heifets, L., Sanchez, T., Vanderkolk, J., & Pham, V. (1999). Development of rifapentine susceptibility tests for Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 43(1), 25–28. https://doi.org/10.1128/aac.43.1.25

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free